Online inquiry

IVTScrip™ mRNA-Human AFF1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10182MR)

This product GTTS-WK10182MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 2-Thio-UTP. It ecodes the AFF1 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 2-Thio-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001166693.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 4299
UniProt ID P51825
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AFF1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) (GTTS-WK10182MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK11330MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK7437MR IVTScrip™ mRNA-Human ADGRE2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRE2
GTTS-WK26849MR IVTScrip™ mRNA-Human ARL6IP5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARL6IP5
GTTS-WK15201MR IVTScrip™ mRNA-Human ANKRD13D, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD13D
GTTS-WK23595MR IVTScrip™ mRNA-Human ASB13, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ASB13
GTTS-WK19269MR IVTScrip™ mRNA-Human AKIRIN1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AKIRIN1
GTTS-WK7660MR IVTScrip™ mRNA-Human ACTG2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACTG2
GTTS-WK19703MR IVTScrip™ mRNA-Human ANKRD17, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD17
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →